Theravance Biopharma (TBPH) Receivables - Net (2013 - 2019)
Theravance Biopharma (TBPH) reported Receivables - Net of $87000.0 for Q3 2019, down 97.12% year-over-year from $3.0 million in Q3 2018, and down 21.62% on a QoQ basis from $111000.0 in Q2 2019.
Theravance Biopharma (TBPH) has 7 years of Receivables - Net data on file, last reported at $87000.0 in Q3 2019.
- Quarterly Receivables - Net fell 97.12% year-over-year to $87000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $87000.0 (down 97.12% YoY) and the FY2018 annual result came in at $620000.0, down 72.48% from the prior year.
- Receivables - Net slipped to $87000.0 in Q3 2019 per TBPH's latest filing, from $111000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $3.4 million in Q2 2018 and bottomed at $87000.0 in Q3 2019.
- The 5-year median for Receivables - Net is $1.2 million (2017), against an average of $1.3 million.
- The widest annual swing landed in 2015, when Receivables - Net jumped 18733.33%; it then slumped 97.12% in 2019.
- Tracing TBPH's Receivables - Net over 5 years: stood at $1.9 million in 2015, then plunged by 66.39% to $646000.0 in 2016, then soared by 248.76% to $2.3 million in 2017, then plunged by 72.48% to $620000.0 in 2018, then slumped by 85.97% to $87000.0 in 2019.
- Per Business Quant, the three latest TBPH Receivables - Net figures stand at $87000.0 (Q3 2019), $111000.0 (Q2 2019), and $113000.0 (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 87,000.00 |
| Sep 30, 2019 | 87,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Sep 30, 2018 | 3.02 Mn |
| Sep 30, 2018 | 3.02 Mn |
| Jun 30, 2018 | 3.43 Mn |
| Jun 30, 2018 | 3.43 Mn |
| Mar 31, 2018 | 1.97 Mn |
| Mar 31, 2018 | 1.97 Mn |
| Dec 31, 2017 | 2.25 Mn |
| Dec 31, 2017 | 2.25 Mn |
| Sep 30, 2017 | 1.58 Mn |
| Sep 30, 2017 | 1.58 Mn |
| Jun 30, 2017 | 1.35 Mn |
| Jun 30, 2017 | 1.35 Mn |
| Mar 31, 2017 | 1.23 Mn |
| Mar 31, 2017 | 1.23 Mn |
| Dec 31, 2016 | 646,000.00 |
| Dec 31, 2016 | 646,000.00 |
| Sep 30, 2016 | 873,000.00 |
| Sep 30, 2016 | 873,000.00 |
| Jun 30, 2016 | 1.86 Mn |
| Jun 30, 2016 | 1.86 Mn |
| Mar 31, 2016 | 1.53 Mn |
| Mar 31, 2016 | 1.53 Mn |
| Dec 31, 2015 | 1.92 Mn |
| Dec 31, 2015 | 1.92 Mn |
| Sep 30, 2015 | 783,000.00 |
| Sep 30, 2015 | 783,000.00 |
| Jun 30, 2015 | 805,000.00 |
| Jun 30, 2015 | 805,000.00 |
| Mar 31, 2015 | 565,000.00 |
| Mar 31, 2015 | 565,000.00 |
| Dec 31, 2014 | 289,000.00 |
| Dec 31, 2014 | 289,000.00 |
| Sep 30, 2014 | 230,000.00 |
| Sep 30, 2014 | 230,000.00 |
| Jun 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 90,000.00 |
| Mar 31, 2014 | 3,000.00 |
| Mar 31, 2014 | 3,000.00 |
| Dec 31, 2013 | 199,000.00 |
| Dec 31, 2013 | 199,000.00 |